Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era: comment

被引：1
|
作者：
Kapoor, Kapil G. [1 ]
Gibran, Syed K. [1 ]
机构：
[1] Univ Texas Med Branch Galveston, Dept Ophthalmol & Visual Sci, Galveston, TX USA
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2011年 / 39卷 / 09期
关键词：
D O I：
10.1111/j.1442-9071.2011.02597.x
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：918 / 919
页数：2
相关论文
共 50 条
  • [31] Oral manifestations of HIV in children receiving anti-retroviral therapy in Hyderabad, India
    Baghirath P.V.
    Krishna A.B.
    Gannepalli A.
    Ali M.M.
    European Archives of Paediatric Dentistry, 2013, 14 (6) : 389 - 395
  • [32] Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART)
    Chiriboga, CA
    Fleishman, S
    Champion, S
    Gaye-Robinson, L
    Abrams, EJ
    JOURNAL OF PEDIATRICS, 2005, 146 (03): : 402 - 407
  • [33] ACUTE KIDNEY INJURY AND CHRONIC KIDNEY DISEASE IN HIV PATIENTS IN THE ERA OF ANTI-RETROVIRAL THERAPY
    Patil, Priya V.
    Bansode, Jyoti B.
    Kore, Manoj C.
    Hajare, Kashmira
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (09): : 1082 - 1086
  • [34] Dermatological Adverse Drug Reactions with Highly Active Anti-Retroviral Therapy
    Allan, E. G.
    Allan, P. S.
    DRUG SAFETY, 2014, 37 (10) : 847 - 848
  • [35] Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients
    Amirayan-Chevillard, N
    Tissot-Dupont, H
    Capo, C
    Brunet, C
    Dignat-George, F
    Obadia, Y
    Gallais, H
    Mege, JL
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (01): : 107 - 112
  • [36] Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients
    de Olalla, PG
    Martínez-González, MA
    Caylà, JA
    Jansà, JM
    Iglesias, B
    Guerrero, R
    Marco, A
    Gatell, JM
    Ocaña, I
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2002, 6 (12) : 1051 - 1057
  • [37] Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy
    Portilla, J
    Boix, V
    Román, F
    Reus, S
    Merino, E
    JOURNAL OF INFECTION, 2000, 41 (02) : 182 - 184
  • [38] Tooth wear in patients treated with HIV anti-retroviral therapy
    Sehgal, Harjit Singh
    Kohli, Richie
    Pham, Edward
    Beck, Grace E.
    Anderson, Jay R.
    BMC ORAL HEALTH, 2019, 19 (1)
  • [39] Psychological distress as a risk factor for non-adherence to Highly active anti-retroviral\therapy
    Nakimuli-Mpungu, Etheldreda
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 : 155 - 155
  • [40] Recognizing cognitive and psychiatric changes in the post-highly active antiretroviral therapy era
    Carvalhal, Adriana
    Baril, Jean-Guy
    Crouzat, Frederic
    De Wet, Joss
    Junod, Patrice
    Kovacs, Colin
    Sheehan, Nancy
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2012, 23 (04): : 209 - 215
12345